Therefore, future studies on manipulating the glucose microenvironment, combined with targeting the USP11/LSH/CYP24A1 signaling axis to enhance cell sensitivity to ferroptosis, may have important implications for the treatment of CRC. Here, HELLS is linked to colorectal carcinoma.